Full Press Release Details
FAQ – Change of company name from ‘Prima BioMed Limited’ to ‘Immutep Limited’.
IMMP
FAQ – Change of company name from ‘Prima BioMed Limited’ to ‘Immutep Limited’
Key Takeaway: FAQ – Change of company name from ‘Prima BioMed Limited’ to ‘Immutep Limited’
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)